2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13±³À°ÀÏÀÚ : 2020-03-13
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿ÈúÈ£ÅÚ VISTA
±³À°ÁÖÁ¦ :
2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ)ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ï 100,000¿ø ÇöÀåµî·Ï 200,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-13 VISTA 1 09:00~09:20 The Evil Side of Gene Regulation in AML Ruud delwel(Erasmus MC University 'The Netherlands)
±³À°½Ã°£ 03-13 VISTA 1 09:20~09:40 Clonal Evolution under IDH Inhibitor Therapy in Acute Myeloid Leukaemia Lynn Quek UK(University of Oxford UK)
±³À°½Ã°£ 03-13 VISTA 1 09:40~10:00 TET Loss-of-Function in Malignant Hematopoiesis Myunggon Ko(UNIST)
±³À°½Ã°£ 03-13 VISTA 1 10:00~10:30 NRAS Mutant AML Taebo Sim(KU-KIST)
±³À°½Ã°£ 03-13 VISTA 1 10:45~11:15 Translational Cancer Research in B-Cell Malignancies John Gribben(Barts Cancer Institute UK)
±³À°½Ã°£ 03-13 VISTA 1 11:15~11:45 Myelodysplastic Syndrome and Predisposition to Myeloid Neoplasia in Children and Adolescents Charlotte Niemeyer(University of Freiburg Germany)
±³À°½Ã°£ 03-13 VISTA 1 11:45~12:05 Outcome of Autologous Transplant in T Cell Lymphoma: Experience of NIHBT in Vietnam Nguyen Vu Bao Anh(Hanoi Medical University Vietnam)
±³À°½Ã°£ 03-13 VISTA 1 12:05~12:25 Subcutaneous Panniculitis-like T-cell Lymphoma Udomsak Bunworasate(King Chulalongkorn Memorial Hosptal Thailand)
±³À°½Ã°£ 03-13 VISTA 1 12:25~12:45 Update of Extranodal NK/T-cell Lymphoma: Treatment and Biology Seok Jin Kim(Sungkyunkwan University)
±³À°½Ã°£ 03-13 VISTA 1 12:45~13:40 Optimizing Treatment of IMiDs in Newly Diagnosed Multiple Myeloma Philippe Moreau(Nantes University Hospital France)
±³À°½Ã°£ 03-13 VISTA 1 14:10~15:10 Heterogeneous outcome after allogeneic stem cell transplantation according to type of KIT mutation in Core binding factor acute myeloid leukemia (CBF-AML): D816V and/or D816Y mutation represents worst outcome Silvia Park(Catholic University of Korea)
±³À°½Ã°£ 03-13 VISTA 1 15:25~16:25 Clinical Significance Of Genetic And Epigenetic Expression of PTEN In Chronic Myeloidic Leukemia Patients Asgar Ali(India Institute of Medical Sciences Patna India)
±³À°½Ã°£ 03-13 VISTA 1 16:40~17:10 Challenges in the Diagnosis of Bone Marrow Failure Syndromes: The Role of Genetic Panels? Ghulam J Mufti(King's College Hospital UK)
±³À°½Ã°£ 03-13 VISTA 1 17:10~17:40 Clonal Hematopoesis in Bone Marrow Failure Daria V. Babushok(University of Pennsylvania USA)
±³À°½Ã°£ 03-13 VISTA 1 17:40~18:10 he Current Treatment Algorithm for Patients with Acquired Aplastic Anemia in Japan Shinji Nakao(Kanazawa University Japan)